SCHEMBL20122547

SCHEMBL20122547

CC(=O)OCOC(=O)SC[C@H](NC(=O)C(C)(C)S)C(=O)OCc1oc(=O)oc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20122441 0.92 MME (0.31) —
SCHEMBL20122364 0.91 — —
SCHEMBL20122542 0.90 — —
SCHEMBL20122437 0.89 — —
SCHEMBL20122559 0.88 CYP1A2 (0.33) —
SCHEMBL20122563 0.87 MME (0.30) —
SCHEMBL20122496 0.87 ACE (0.34) —
SCHEMBL20122560 0.85 CYP1A2 (0.31) —
SCHEMBL20122450 0.85 ACE (0.37) —
SCHEMBL20122564 0.84 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963428-B1 Bucillamine prodrugs, pharmaceutical compositions thereof, and methods of use Nguyen, Mark Quang (US) 2018-05-08 — — US disclosed
Send feedback